These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12932077)

  • 1. Targeting retroviral and lentiviral vectors.
    Sandrin V; Russell SJ; Cosset FL
    Curr Top Microbiol Immunol; 2003; 281():137-78. PubMed ID: 12932077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying the host range properties of retroviral vectors.
    Russell SJ; Cosset FL
    J Gene Med; 1999; 1(5):300-11. PubMed ID: 10738547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
    Beyer WR; Westphal M; Ostertag W; von Laer D
    J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
    Bartosch B; Cosset FL
    Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping.
    Kim SH; Lim KI
    Mol Cells; 2017 May; 40(5):339-345. PubMed ID: 28535668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.
    Kuhn U; Terunuma A; Pfutzner W; Foster RA; Vogel JC
    J Virol; 2002 Feb; 76(3):1496-504. PubMed ID: 11773422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altering the tropism of lentiviral vectors through pseudotyping.
    Cronin J; Zhang XY; Reiser J
    Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress with retroviral gene vectors.
    Palù G; Parolin C; Takeuchi Y; Pizzato M
    Rev Med Virol; 2000; 10(3):185-202. PubMed ID: 10815029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Library selection approaches to engineering enhanced retroviral and lentiviral vectors.
    Lim KI; Schaffer DV
    Comb Chem High Throughput Screen; 2008 Feb; 11(2):111-7. PubMed ID: 18336204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postexit surface engineering of retroviral/lentiviral vectors.
    Metzner C; Kochan F; Dangerfield JA
    Biomed Res Int; 2013; 2013():253521. PubMed ID: 23691494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.
    Sinn PL; Coffin JE; Ayithan N; Holt KH; Maury W
    Methods Mol Biol; 2017; 1628():65-78. PubMed ID: 28573611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for targeting lentiviral vectors.
    Frecha C; Szécsi J; Cosset FL; Verhoeyen E
    Curr Gene Ther; 2008 Dec; 8(6):449-60. PubMed ID: 19075628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
    Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
    Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Transduction of Zebrafish Melanoma Cell Lines and Embryos Using Lentiviral Vectors.
    Fazio M; Avagyan S; van Rooijen E; Mannherz W; Kaufman CK; Lobbardi R; Langenau DM; Zon LI
    Zebrafish; 2017 Aug; 14(4):379-382. PubMed ID: 28557653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
    Sinn PL; Sauter SL; McCray PB
    Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexibility in cell targeting by pseudotyping lentiviral vectors.
    Bischof D; Cornetta K
    Methods Mol Biol; 2010; 614():53-68. PubMed ID: 20225035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral approaches to gene therapy of cystic fibrosis.
    Johnson LG
    Ann N Y Acad Sci; 2001 Dec; 953():43-52. PubMed ID: 11795422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified envelope glycoproteins to retarget retroviral vectors.
    Haynes C; Erlwein O; Schnierle BS
    Curr Gene Ther; 2003 Oct; 3(5):405-10. PubMed ID: 14529348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retroviral vector family: something for everyone.
    Elsner C; Bohne J
    Virus Genes; 2017 Oct; 53(5):714-722. PubMed ID: 28762206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.